Therapeutic advances of targeting receptor tyrosine kinases in cancer
Abstract Receptor tyrosine kinases (RTKs), a category of transmembrane receptors, have gained significant clinical attention in oncology due to their central role in cancer pathogenesis. Genetic alterations, including mutations, amplifications, and overexpression of certain RTKs, are critical in cre...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2024-08-01
|
| Seri Bilgileri: | Signal Transduction and Targeted Therapy |
| Online Erişim: | https://doi.org/10.1038/s41392-024-01899-w |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|